Saturday 17 October 2026
Export BACK’s income statement to Excel — free account
IMAC Holdings, Inc.
BACK Healthcare Medical Care Facilities
IMAC Holdings, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $72,100.00, down 99.6% from fiscal 2022. In the quarter to September 2025, revenue grew 34.2%, EPS grew 16.7% and free cash flow fell 30.9%, each against the same quarter a year earlier.
0.00
0.00
NaN
Follow BACK
| Older periods | Dec '24 | Mar '25 | Jun '25 | Sep '25 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | — | 0.00 |
P/S ratio |
1.22 | 2.57 | — | 3.35 | |
P/FCF ratio |
0.00 | 0.00 | — | 0.00 | |
P/Operating CF |
(1.75) | (0.18) | — | (0.18) | |
P/B ratio |
0.00 | 0.00 | — | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | — | 0.00 | |
EV/Sales |
0.98 | 3.63 | — | 4.17 | |
EV/EBITDA |
0.00 | 0.00 | — | 0.00 | |
EV/Operating CF |
(0.51) | (0.07) | — | (0.07) | |
EV/FCF |
(0.64) | (0.08) | — | (0.08) | |
Quick Ratio |
0.07 | 0.00 | 0.00 | 0.00 | |
Current Ratio |
0.09 | 0.03 | 0.03 | 0.02 | |
Net Debt/EBITDA |
0.29 | 0.01 | 0.02 | 0.02 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
1.20 | 0.07 | 0.00 | 0.09 | |
Operating CF/Net income |
0.18 | 0.30 | 0.39 | 0.33 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
(3.50) | (190.34) | (13.31) | (5.58) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | — | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 139,146.67% | 0.00% | 8,258.49% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | — | 0.00% | |
Graham Net Nets |
(3.28) | (44.92) | — | (48.98) | |
Graham Number |
22.97 | 19.90 | — | 21.87 | |
Earnings Yield |
(514.28%) | (12,102.17%) | — | (8,859.00%) | |
Free Cash Flow Yield |
(124.99%) | (1,759.37%) | — | (1,596.19%) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.01 | |
Operating CF per Share |
(0.72) | (0.33) | (0.34) | (0.38) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.72) | (0.33) | (0.34) | (0.38) | |
Cash per Share |
0.32 | 0.01 | 0.01 | 0.01 | |
Shareholders Equity per Share |
(3.59) | (2.42) | (2.60) | (3.43) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(3.59) | (2.42) | (2.60) | (3.43) | |
Free Cash Flow |
(1.14) | (1.03) | (1.30) | (1.43) | |
Working Capital |
(6.54) | (8.48) | (10.63) | (12.98) | |
Net Current Asset Value |
(6.54) | (8.48) | (10.63) | (12.98) | |
EV/EBIT |
0.00 | 0.00 | — | 0.00 | |
Capex to Sales |
0.00 | 0.00 | — | 0.00 | |
Price to Operating Income |
0.00 | 0.00 | — | 0.00 | |
| Other line items | |||||
Average Receivables |
0.35 | — | — | — | |
Average Payables |
1.58 | 2.34 | 2.91 | 3.59 | |
Average Assets |
1.37 | 1.03 | 1.65 | 0.89 | |
Average Common Equity |
(3.20) | (4.44) | (5.80) | (8.51) |
Columns are period end dates